Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neuroblastoma 3 Lymphoma 3 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Unspecified Childhood Solid Tumor, Protocol Specific 1 Subcutaneous panniculitis-like T-cell lymphoma 1 Sertoli-Leydig Cell Tumor 1 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian gynandroblastoma 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Neoplasms 1 Leukemia 1 Immunoblastic Lymphadenopathy 1 Granulosa cell tumor of the ovary 1 Glioma 1 Fallopian Tube Neoplasms 1 Enteropathy-Associated T-Cell Lymphoma 1 Carcinoma, Ovarian Epithelial 1

Interventions

Exercise 19 Drug Therapy 18 pembrolizumab 13 Capecitabine 11 Blood Specimen Collection 11 Surveys and Questionnaires 10 Radiotherapy 10 Paclitaxel 9 Dexamethasone 9 Nivolumab 8 Standard of Care 7 Oxaliplatin 7 Fluorouracil 7 Erlotinib Hydrochloride 7 apatinib 6 Interviews as Topic 6 Gemcitabine 6 Control Groups 6 Cisplatin 6 Therapeutics 5 Neoadjuvant Therapy 5 Mindfulness-Based Cognitive Therapy 5 Metformin 5 Injections 5 Everolimus 5 Docetaxel 5 Cyclophosphamide 5 Bevacizumab 5 sintilimab 4 atezolizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms × etoposide phosphate × Clear all

NCT02015728 2016-12-15

SEED

Seattle Children's Hospital

Phase NA Unknown

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡